1. Home
  2. BGC vs KRYS Comparison

BGC vs KRYS Comparison

Compare BGC & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGC Group Inc.

BGC

BGC Group Inc.

HOLD

Current Price

$9.11

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$253.36

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGC
KRYS
Founded
1945
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
6.3B
IPO Year
1999
2017

Fundamental Metrics

Financial Performance
Metric
BGC
KRYS
Price
$9.11
$253.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$14.50
$214.22
AVG Volume (30 Days)
2.7M
322.3K
Earning Date
11-06-2025
11-03-2025
Dividend Yield
0.89%
N/A
EPS Growth
36.46
275.72
EPS
0.33
6.66
Revenue
$2,640,884,000.00
$373,164,000.00
Revenue This Year
$36.34
$36.14
Revenue Next Year
$11.45
$41.80
P/E Ratio
$27.20
$37.47
Revenue Growth
24.59
54.51
52 Week Low
$7.24
$122.80
52 Week High
$10.96
$249.78

Technical Indicators

Market Signals
Indicator
BGC
KRYS
Relative Strength Index (RSI) 58.34 75.77
Support Level $8.89 $231.69
Resistance Level $9.05 $248.60
Average True Range (ATR) 0.18 8.22
MACD 0.04 0.44
Stochastic Oscillator 89.29 97.16

Price Performance

Historical Comparison
BGC
KRYS

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: